Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1214

1.

Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.

Ateş A, Karaaslan Y, Aksaray S.

Clin Rheumatol. 2007 Apr;26(4):499-504. Epub 2006 May 3.

PMID:
16670828
2.

Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.

Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA.

J Rheumatol. 2002 Oct;29(10):2074-6.

PMID:
12375314
3.

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.

Arthritis Rheum. 2000 Jan;43(1):155-63.

4.

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.

J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.

PMID:
16924694
5.
7.

Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.

Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, Dijkmans BA, Hamann D.

Ann Rheum Dis. 2005 Aug;64(8):1199-204. Epub 2005 Jan 7.

8.

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K.

Ann Rheum Dis. 2004 Sep;63(9):1079-84.

9.

[Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].

Yang CL, Zhou YR, Zhou F, Li J.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1277-9. Chinese.

10.

Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.

Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J.

N Z Med J. 2004 Oct 8;117(1203):U1097.

PMID:
15477921
12.

Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?

Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG.

Eur Ann Allergy Clin Immunol. 2004 Apr;36(4):127-30.

PMID:
15180353
13.

Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.

Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.

J Rheumatol. 2003 Jul;30(7):1451-5.

PMID:
12858440
14.

[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].

Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.

Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.

PMID:
19149089
15.

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis.

Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK.

Arthritis Res Ther. 2010;12(3):R76. doi: 10.1186/ar2995. Epub 2010 May 5.

16.

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.

17.

Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.

García-Berrocal B, González C, Pérez M, Navajo JA, Moreta I, Dávila C, González-Buitrago JM.

Clin Chim Acta. 2005 Apr;354(1-2):123-30.

PMID:
15748608
18.

Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.

Nikolaisen C, Rekvig OP, Nossent HC.

Scand J Rheumatol. 2007 Mar-Apr;36(2):97-100.

PMID:
17476614
19.

Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients.

Gupta R, Thabah MM, Aneja R, Kumar A, Varghese T, Chandrasenan PJ.

Indian J Med Sci. 2009 Mar;63(3):92-100.

PMID:
19359776
20.

Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.

Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.

J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.

PMID:
19286846

Supplemental Content

Support Center